Diseases & Disorders
(G32)
IRS Verified
DX Registered
990 on File
ROCKING THE ROAD FOR A CURE INC
Financial strength (30%)
65/100
Reliability (20%)
50/100
Effectiveness (25%)
53/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$65K
Total Revenue
$51K
Total Expenses
$15K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
58.4%
Fundraising Efficiency
40.0%
Operating Reserve
3.45x
Liability-to-Asset
54.1%
Revenue Diversification
30.2%
Compared with Peers
FY 2024
Compared with 1,426 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
58.4% | 80.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
40.0% | 40.8% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
3.5 mo | 23.3 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
54.1% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
30.2% | 99.5% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
1.8% | -0.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-7.8% | 0.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
20.8% | 8.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $65K | $51K | $15K | 58.4% | — |
| 2023 | $64K | $56K | $1K | 48.6% | — |
| 2022 | $56K | $69K | $-6,689 | 47.7% | — |
| 2021 | $53K | $55K | $6K | 90.2% | — |
| 2020 | $0 | $0 | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.